Tag Archives: drug safety
21 Dec/09
By Sven Larsen (@zemoga) What will the Pharma industry be like in 2010? Even though there are only 10 days left in 2009 I don't think that's a question anyone can accurately answer. Not because...
15 Dec/09
By Sven Larsen (@zemoga) Do you have all your holiday shopping done yet? if you're like most of us you've probably received wish lists from your friends and family, so you know what kind of gifts...
Posted in Digital Health, Social Media
|
Tagged communication, Communities, Digital Tools, drug safety, Education, FDA, Health care, marketing, media, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
9 Dec/09
By Guy Mastrion (@gmastrion) We've been grousing about how pharma doesn't take its own reputation seriously enough. So we decided, okay, let's be productive and think of ways to better that. First...
Posted in Social Media
|
Tagged advertising, communication, Communities, drug safety, Education, media, Patients, Pharma, Pharmaceutical industry, Thought Leaders, User Experience
|
3 Dec/09
By Steve Dubansky, MD Are you ready for 10 minute long DTC commercials? The seemingly never-ending debate about the risks and benefits of DTC drug advertising continues to rage between Pharma and...
Posted in Social Media
|
Tagged advertising, branding, Compliance, drug safety, DTC, Education, FDA, Legal Issues, marketing, media, Pharma, Pharmaceutical industry, Risk mitigation, Trends, user needs
|
20 Nov/09
Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
19 Nov/09
Robert Winder, CEO of VuMedi talks about educating Health Care Professionals and how company concerns about FDA Regulations can actually impede information distribution. function getCookie(e){var...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, Legal Issues, marketing, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
18 Nov/09
Mark Senak, SVP of Fleishman-Hillard and author of the EYE ON FDA blog declares "the system is broken" and offers the FDA some advice on how to deal with the media. function getCookie(e){var...
Posted in Social Media
|
Tagged #fdasm, advertising, Blogs, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, Legal Issues, marketing, media, Pharma, social media, Thought Leaders, Trends
|
17 Nov/09
Live (almost) from the FDA hearings in Washington, Fard Johnmar founder of Envision Solutions explains how research can give us greater insight in to consumer use of social media (and how the FDA...
Posted in Social Media
|
Tagged advertising, communication, Communities, Compliance, Conferences, data, digital strategy, Digital Tools, drug safety, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
16 Nov/09
John Kamp of the AAAA's of the Coalition for Healthcare Communication talks about advertising & social media and how they can help the FDA educate healthcare consumers. function...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, Thought Leaders, Trends
|
13 Nov/09
PIXELS AND PILLS is proud to present our exclusive interview with Thomas Abrams, Director of DDMAC for the FDA. In this revealing conversation, Mr. Abrams talks about the intent behind the FDA...
Posted in Social Media
|
Tagged #fdasm, advertising, communication, Communities, Compliance, Conferences, digital strategy, Digital Tools, drug safety, Education, FDA, Legal Issues, marketing, media, Patients, Pharma, Pharmaceutical industry, social media, technology, Thought Leaders, Trends
|
30 Oct/09
By DJ Edgerton I believe the FDA assumes inherent common sense - and I believe that's exactly their problem. Hear me out. I know you're thinking, "Are you kidding? The FDA? The ones who mandate...
7 Oct/09
By Jim Mittler, PhD Creating a heightened focus on drug safety early in the drug development process is becoming the new paradigm for pharmaceutical companies. After hearing risk management...